SMS PHARMACEUTICALS
Back to Balance Sheet
|
SMS PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹48 Cr | ₹43 Cr | ₹41 Cr | ₹40 Cr | ₹54 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of SMS PHARMACEUTICALS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹48 Cr |
| Mar2024 | ₹43 Cr |
| Mar2023 | ₹41 Cr |
| Mar2022 | ₹40 Cr |
| Mar2021 | ₹54 Cr |
How is Deferred Tax Assets / Liabilities of SMS PHARMACEUTICALS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹48 Cr | 12.38 | |
| Mar2024 | ₹43 Cr | 4.34 | |
| Mar2023 | ₹41 Cr | 3.71 | |
| Mar2022 | ₹40 Cr | -26.56 | |
| Mar2021 | ₹54 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of SMS PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SMS PHARMACEUTICALS | ₹3,715.7 Cr | -4.9% | 3.1% | 91.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹388,680.0 Cr | -2.9% | -8.9% | -3.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,817.0 Cr | 1.2% | 4.2% | 8.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹139,297.0 Cr | -1.7% | -3.6% | 27.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,828.0 Cr | 6.8% | 1.3% | 13.2% | Stock Analytics | |
| CIPLA | ₹104,588.0 Cr | 5.4% | 3.1% | -13.6% | Stock Analytics | |
SMS PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SMS PHARMACEUTICALS | -4.9% |
3.1% |
91.4% |
| SENSEX | -2.3% |
3.3% |
-2.4% |
You may also like the below Video Courses